Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tranexamic acid after sinonasal surgery
ACTRN12625001412426Phase 2Not yet recruiting
- Sponsor
- Metro North Health
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in epistaxis comparing Oral tranexamic acid with Placebo (2 arms). Primary endpoint: Patient perception of the impact of epistaxis. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
epistaxis
Beyond the preview
Go deeper on ACTRN12625001412426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001412426.